Jonathan Staidle, MD
Dermatology · Sparks, NVNPI 1982994455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 34.9% of the total. 2025 is the largest year on record at $889, 4.9 times the $181 reported in 2019. That places this record below the midpoint for dermatology clinicians in NV, where the typical reported total is $3,854.
Across 168 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$490
- Lilly USA, LLC$243
- Novartis$213
- Amgen$202
- Sun Pharmaceutical Industries Inc.$148
- plus $779 from 16 others
What the payments were for
- Food & beverage$3,08997%
- Education$963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,110 |
| Johnson & Johnson | 24 | $490 |
| Lilly USA, LLC | 16 | $243 |
| Novartis | 8 | $213 |
| Amgen | 10 | $202 |
| Sun Pharmaceutical Industries Inc. | 8 | $148 |
| E.r. Squibb & Sons, L.L.C. | 6 | $131 |
| LEO Pharma Inc. | 6 | $120 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $117 |
| Pfizer | 4 | $79 |
| Sanofi | 2 | $63 |
| Dermira, Inc. | 3 | $49 |
| Galderma Laboratories, L.p. | 3 | $46 |
| UCB, Inc. | 2 | $31 |
| VYNE Pharmaceuticals Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Almirall LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Mission Pharmacal Company | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Prugen, Inc. Pharmaceuticals | 1 | $11 |
How this compares
$3,185 in reported general payments places this provider in the 45th percentile of 78 dermatology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minocycline Hcl | 15 | $845 |
| Doxycycline Monohydrate | 70 | $638 |
| Ketoconazole | 30 | $633 |
| Triamcinolone Acetonide | 29 | $435 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $231 |
| Hydrocortisone | 16 | $86 |
| Amoxicillin | 41 | $83 |
| Ibuprofen | 17 | $58 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sparks
- Irene ManneringSparks$9K
- David CotterLas Vegas$1.4M
- Harry GreenbergLas Vegas$1.1M
- Miriam BettencourtLas Vegas$772K
- Victoria FarleyLas Vegas$151K
- Curt SamlaskaHenderson$101K
- Laura OstezanReno$27K
- Robert LiebermanHenderson$22K
- Linda WoodsonLas Vegas$22K
- Candace SpannLas Vegas$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.